Liquid Biopsy Market: Global Industry Analysis and Forecast 2021-2026

1
Presents a Research Report on Liquid Biopsy
Market
According to a report published by The World
Health Organization in 2017, the number of breast
cancer deaths around the globe is expected to
increase. By 2040, more than 991,000 women are
expected to die annually of breast cancer across
the globe. 


www.stratviewresearch.com
Market Reports
Advisory Consulting
Sourcing Intelligence
2
Liquid Biopsy Market Highlights Drivers

• Liquid Biopsy Market size is expected to grow at
  a strong CAGR during the next five years.
• Liquid biopsy, also known as fluid
  biopsy or fluid phase biopsy, is the sampling and
  analysis of non-solid biological tissue, mainly
  blood. This technique is mainly used as a
  diagnostic and monitoring tool for diseases such
  as cancer, with an added benefit of being largely
  non-invasive.
•  

• Market Dynamics
• The potential for liquid biopsies to lead to
  early detection of cancer may impact several
  product lines, mainly critical illness (CI) and
  medical insurance. Over the past few years, CI
  has undergone several innovations. Companies now
  offer staged, multi-pay, and cancer-only plans. A
  unique selling point of cancer-only and staged CI
  plans is they cover early-stage cancers as well.
  Increased near-term utilization of liquid biopsy
  as part of routine screening tests or diagnostic
  protocols could lead to higher cancer incidence
  rates than anticipated. This could impact the
  pricing assumptions of certain products,
  especially those offering early-stage cancer
  benefits.

3
Market Insight

• Recent mainstream news flow has made much of the
  CancerSEEK diagnostic test, particularly its
  ability to detect multiple types of cancer from a
  single blood sample. In reality, further
  confirmatory tests will be required
  post-screening before a patient is placed on the
  current standard of care for their particular
  cancer. Also, the tests sensitivity falls to 70
  for the purposes of screening certain cancers,
  which is insufficient to drive standalone
  clinical decisions. Therefore, considerable
  further development and validation of liquid
  biopsy-type platforms are required to establish
  such a one stop diagnostic test. Among the key
  competitors in liquid biopsy, Biocept, Oncocyte
  and few others are creating buzz in the market.
• Overall, the liquid biopsy (LB) concept
  complements the personalized medicine approach
  and provides an innovative way for patient
  selection in clinical trials, here mutational
  analysis supports patient eligibility for
  targeted therapy.
• While we do not anticipate that LB will fully
  replace or directly compete with SB for most
  diagnostic purposes any time soon, we do very
  much foresee that LB will complement SB rapidly
  within the next 35 years and will become a tool
  of choice for dynamic monitoring of patients on
  treatment or under active surveillance. In many
  instances, LB will also prompt further imaging
  workup and/or re-biopsy of tissue lesions.

4
Research Methodology
Data Analysis (Top Down and Bottom Up Approach)
Data Triangulation (Data Evaluation and Multiple
Data Triangulation)
Final Deliverables (Final Report with All
Findings)
Stratview Research follows a rigorous methodology
with high emphasis on primary research and
multiple ways of data triangulation. We conduct
primary research across the value chain to
provide 360 degree view of the market.
Secondary Research
Stratview Research Internal Knowledgebase
Primary Research

• Annual Reports / Fact Book
• Company Websites
• Magazines / Publications
• Press Releases Journals
• Industry News
• Association Articles
• Government Documents
• Social Media
• Others

• Robust database across value chain
• In-house industry veterans as advisors
• Project based subject matter experts

• Industry Players
• Industry Experts
• Suppliers
• Customers
• Associations
• Government Institutions
• Others

5
Report Features

• This report provides market intelligence in the
  most comprehensive way. The report structure has
  been kept such that it offers maximum business
  value. It provides critical insights on the
  market dynamics and will enable strategic
  decision making for the existing market players
  as well as those willing to enter the market. The
  following are the key features of the report
• Market structure Overview, industry life cycle
  analysis, supply chain analysis.
• Market environment analysis Growth drivers and
  constraints, Porters five forces analysis, SWOT
  analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics Market share,
  product portfolio, product launches, etc.
• Attractive market segments and associated growth
  opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing
  and new players.
• Key success factors.

6
About Stratview Research
Stratview Research is a global market
intelligence firm providing high quality
syndicated reports, custom research and
consulting services.
Our Services
Why Us?
High Customer Delight
Rich Industry Experience
Robust Methodology
Effective Business Decisions
7
Contact Us for More Information and Sample Pages
Ask for Sample Pages here https//www.stratviewr
esearch.com/Request-Sample/422/liquid-biopsy-diagn
ostic-market.htmlform Email us
at sales_at_stratviewrsearch.com Call
Us 1-313-307-4176
8
Thank you